Department of Respiratory Virology, Vallabhbhai Patel Chest Institute, University of Delhi, India.
Nucleic Acid Ther. 2013 Oct;23(5):355-62. doi: 10.1089/nat.2013.0432. Epub 2013 Aug 24.
One of the hallmarks of progression of influenza virus replication is the step involving the virus uncoating that occurs in the host cytoplasm. The BM2 ion channel protein of influenza B virus is highly conserved and is essentially required during the uncoating processes of virus, thus an attractive target for designing antiviral drugs. We screened several DNA enzymes (Dzs) containing the 10-23 catalytic motif against the influenza B virus BM2 RNA. Dzs directed against the predicted single-stranded bulge regions showed sequence-specific cleavage activities. The Dz209 not only showed significant intracellular reduction of BM2 gene expression in transient-expression system but also provided considerable protection against influenza B virus challenge in MDCK cells. Our findings suggest that the Dz molecule can be used as selective and effective inhibitor of viral RNA replication, and can be explored further for development of a potent therapeutic agent against influenza B virus infection.
流感病毒复制进展的标志之一是病毒在宿主细胞质中的脱壳步骤。乙型流感病毒的 BM2 离子通道蛋白高度保守,在病毒脱壳过程中是必不可少的,因此是设计抗病毒药物的有吸引力的靶标。我们筛选了几种含有 10-23 催化基序的 DNA 酶(Dzs)针对乙型流感病毒 BM2 RNA。针对预测的单链膨出区域的 Dz 显示出序列特异性切割活性。Dz209 不仅在瞬时表达系统中显著降低了 BM2 基因的表达,而且对 MDCK 细胞中的乙型流感病毒攻击提供了相当大的保护。我们的研究结果表明,Dz 分子可用作病毒 RNA 复制的选择性和有效抑制剂,并可进一步探索用于开发针对乙型流感病毒感染的有效治疗剂。